...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript

p.s.  Sorry - tried to fix the spacing since copy and paste inserted so much extra space again, but timed out in the middle of the task.

Share
New Message
Please login to post a reply